Proteomic analysis of hepatocellular carcinoma HepG2 cells treated with platycodin D

Chinese Journal of Natural Medicines

Volumn 13, Issue 9, 2015, Pages 673-679

  Lu, Jin Jian ^a   Lu, De Zhao ^b   Chen, Yu Fei ^b   Dong, Ya Ting ^b   Zhang, Jun Ren ^b   Li, Ting ^a   Tang, Zheng Hai ^a   Yang, Zhen ^b  

^a University of Macau   (Macao)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

2 D DIGE; HepG2; Platycodin D; Proteome

Indexed keywords

40S RIBOSOMAL PROTEIN S12; ANTINEOPLASTIC AGENT; ATP SYNTHASE SUBUNIT D; BARRIER TO AUTOINTEGRATION FACTOR; CELL PROTEIN; COILED COIL DOMIAINING 40 PROTEIN; DELTA(3,5)DELTA(2,4)DIENOYL COA ISOMERASE; ENDOPLASMIC RETICULUM RESIDENT PROTEIN 29; GALECTIN 1; HEAT SHOCK PROTEIN 27; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H; KERATIN TYPE 1 CYTOSKELETAL 9 PROTEIN; KERATIN TYPE II CYTOSKETAL 1 PROTEIN; MYOSIN LIGHT POLYPEPTIDE 6; PLATYCODIN D; PROHIBITIN; PROLIFERATION ASSOCIATED PROTEIN 2G4; PROTEOME; RETICULOCALBIN 1; RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE NEP1; SAPONIN DERIVATIVE; SUCCINYL COA 3 KETOACID COENZYME A TRANSFERASE 1; TRITERPENOID; TROPOMYOSIN ALPHA 3 CHAIN PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN 175; PLANT EXTRACT; SAPONIN; TRITERPENE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG MECHANISM; ETHNOPHARMACOLOGY; HEPG2 CELL LINE; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MTT ASSAY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING; APOPTOSIS; CAMPANULACEAE; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; CHEMISTRY; LIVER NEOPLASMS; METABOLISM; PHYTOTHERAPY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CAMPANULACEAE; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CELL SURVIVAL; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; PROTEOME; PROTEOMICS; SAPONINS; TRITERPENES; UP-REGULATION;

EID: 84942103341     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/S1875-5364(15)30065-0     Document Type: Article

References (36)

1. Ahn KS, Noh EJ, Zhao HL, et al. Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor-kappaB activation in RAW 264.7 cells [J]. Life Sci 2005, 76(20):2315-2328.
2. Kim YP, Lee EB, Kim SY, et al. Inhibition of prostaglandin E2 production by platycodin D isolated from the root of Platycodon grandiflorum [J]. Planta Med 2001, 67(4):362-364.
3. Wu JT, Yang GW, Zhu WX, et al. Anti-atherosclerotic activity of platycodin D derived from roots of Platycodon grandiflorum in human endothelial cells [J]. Bio Pharm Bull 2012, 35(8):1216-1221.
4. Han LK, Zheng YN, Xu BJ, et al. Saponins from platycodi radix ameliorate high fat diet-induced obesity in mice [J]. J Nutr 2002, 132(8):2241-2245.
5. Lee H, Kang R, Kim YS, et al. Platycodin D inhibits adipogenesis of 3T3-L1 cells by modulating Kruppel-like factor 2 and peroxisome proliferator-activated receptor gamma [J]. Phytother Res 2010, 24(Suppl 2):S161-S167.
6. Xie Y, Deng W, Sun H, et al. Platycodin D2 is a potential less hemolytic saponin adjuvant eliciting Th1 and Th2 immune responses [J]. Int Immunopharmacol 2008, 8(8):1143-1150.
7. Choi SS, Han EJ, Lee TH, et al. Antinociceptive mechanisms of platycodin D administered intracerebroventricularly in the mouse [J]. Planta Med 2002, 68(9):794-798.
8. Kim YS, Kim JS, Choi SU, et al. Isolation of a new saponin and cytotoxic effect of saponins from the root of Platycodon grandiflorum on human tumor cell lines [J]. Planta Med 2005, 71(6):566-568.
9. Kim MO, Moon DO, Choi YH, et al. Platycodin D induces mitotic arrest in vitro, leading to endoreduplication, inhibition of proliferation and apoptosis in leukemia cells [J]. Int J Cancer 2008, 122(12):2674-2681.
10. Shin DY, Kim GY, Li W, et al. Implication of intracellular ROS formation, caspase-3 activation and Egr-1 induction in platycodon D-induced apoptosis of U937 human leukemia cells [J]. Biomed Pharmacother 2009, 63(2):86-94.
11. Choi YH, Yoo DS, Cha MR, et al. Antiproliferative effects of saponins from the roots of Platycodon grandiflorum on cultured human tumor cells [J]. J Nat Prod 2010, 73(11):1863-1867.
12. Yu JS, Kim AK Platycodin D induces apoptosis in MCF-7 human breast cancer cells [J]. J Med Food 2010, 13(2):298-305.
13. Kim MO, Moon DO, Choi YH, et al. Platycodin D induces apoptosis and decreases telomerase activity in human leukemia cells [J]. Cancer Lett 2008, 261(1):98-107.
14. Li T, Xu WS, Wu GS, et al. Platycodin D induces apoptosis, and inhibits adhesion, migration and invasion in HepG2 hepatocellular carcinoma cells [J]. Asian Pac J Cancer Prev 2014, 15(4):1745-1749.
15. Tang ZH, Li T, Gao HW, et al. Platycodin D from Platycodonis Radix enhances the anti-proliferative effects of doxorubicin on breast cancer MCF-7 and MDA-MB-231 cells [J]. Chin Med 2014, 9:16.
16. Chun J, Joo EJ, Kang M, et al. Platycodin D induces anoikis and caspase-mediated apoptosis via p38 MAPK in AGS human gastric cancer cells [J]. J Cell Biochem 2013, 114(2):456-470.
17. Chun J, Kim YS Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways [J]. Chem Biol Interact 2013, 205(3):212-221.
18. Yu JS, Kim AK Platycodin D induces reactive oxygen species-mediated apoptosis signal-regulating kinase 1 activation and endoplasmic reticulum stress response in human breast cancer cells [J]. J Med Food 2012, 15(8):691-699.
19. Lu JJ, Chen SM, Zhang XW, et al. The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells [J]. Invest New Drugs 2011, 29(6):1276-1283.
20. Yue QX, Cao ZW, Guan SH, et al. Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network [J]. Mol Cell Proteomics 2008, 7(5):949-961.
21. Mkrtchian S, Baryshev M, Matvijenko O, et al. Oligomerization properties of ERp29, an endoplasmic reticulum stress protein [J]. FEBS Lett 1998, 431(3):322-326.
22. Bambang IF, Xu S, Zhou J, et al. Overexpression of endoplasmic reticulum protein 29 regulates mesenchymal-epithelial transition and suppresses xenograft tumor growth of invasive breast cancer cells [J]. Lab Invest 2009, 89(11):1229-1242.
23. Lessor TJ, Yoo JY, Xia X, et al. Ectopic expression of the ErbB-3 binding protein ebp1 inhibits growth and induces differentiation of human breast cancer cell lines [J]. J Cell Physiol 2000, 183(3):321-329.
24. Lu Y, Zhou H, Chen W, et al. The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells [J]. Breast Cancer Res Treat 2011, 126(1):27-36.
25. Rizwani W, Alexandrow M, Chellappan S Prohibitin physically interacts with MCM proteins and inhibits mammalian DNA replication [J]. Cell Cycle 2009, 8(10):1621-1629.
26. Liu YH, Peck K, Lin JY Involvement of prohibitin upregulation in abrin-triggered apoptosis [J]. Evid Based Complement Alternat Med 2012, 2012:605154.
27. Chen D, Zhang R, Shen W, et al. RPS12-specific shRNA inhibits the proliferation, migration of BGC823 gastric cancer cells with S100A4 as a downstream effector [J]. Int J Oncol 2013, 42(5):1763-1769.
28. Cheng Z, Wang K, Wei J, et al. Proteomic analysis of anti-tumor effects by tetrandrine treatment in HepG2 cells [J]. Phytomedicine 2010, 17(13):1000-1005.
29. Gillenwater A, Xu XC, Estrov Y, et al. Modulation of galectin-1 content in human head and neck squamous carcinoma cells by sodium butyrate [J]. Int J Cancer 1998, 75(2):217-224.
30. Kim HJ, Do IG, Jeon HK, et al. Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer [J]. Hum Pathol 2013, 44(1):62-68.
31. Kuramitsu Y, Taba K, Ryozawa S, et al. Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry [J]. Anticancer Res 2010, 30(9):3367-3372.
32. Lu JJ, Chen SM, Ding J, et al. Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line [J]. Mol Cell Biochem 2012, 360(1-2):329-337.
33. Kamada M, So A, Muramaki M, et al. Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells [J]. Mol Cancer Ther 2007, 6(1):299-308.
34. Diaz-Chavez J, Fonseca-Sanchez MA, Arechaga-Ocampo E, et al. Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy [J]. PLoS One 2013, 8(5):e64378.
35. Qi L, Wu P, Zhang X, et al. Inhibiting ERp29 expression enhances radiosensitivity in human nasopharyngeal carcinoma cell lines [J]. Med Oncol 2012, 29(2):721-728.
36. Zhang D, Putti TC Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells [J]. Exp Cell Res 2010, 316(20):3522-3531.